Abstract
The broad spectrum of in vitro antimicrobial activity and frequent observations of synergy with the combination of trimethoprim and sulfamethoxazole (co-trimoxazole) have lead to its evaluation clinically in a large variety of infectious diseases. Many of these are discussed in other chapters. However, a few notable exceptions remain. The present chapter is a summary of data from studies in a variety of diseases in which the combination has been evaluated in some detail, though well-controlled clinical studies have not been reported in most cases. These include brucellosis, toxoplasmosis, nocardiosis, the “atypical” mycobacterioses, histoplasmosis, paracoccidioidomycosis, phycomycosis, and chromomycosis. A few additional examples are included because of their inherent interest, despite the paucity of available information; i.e., bubonic plaque, Q fever, Isospora belli infections, pneumonitis due to the “Pittsburgh pneumonia agent,” malakoplakia, and pediculosis capitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Adams AR, Jackson JM, Scopa J, Lane GK, Wilson R (1971) Nocardiosis. Diagnosis and management with a report of three cases. Med J Aust 1 (13): 669–674
Adams HG, Brooks GF (1977) In vitro sulfamethoxazole-trimethoprim activity against No-cardia asteroides: efficacious therapy in five patients with Nocardia pneumonia. Abstr, 17th ICAAC, October 1977. Obtainable from: American Society for Microbiology, Washington, DC
Alberola V, Marin J, Abellan MT, Bori JV, Pascual-Leone A (1969) A study of the antibacterial association of trimethoprim and sulfamethoxazole in sundry infections. Med Esp 62 (368): 382–387
Appelbaum PC, Bowen AJ (1978) Opportunistic infection of chronic skin ulcers with Pseudomonas putrefaciens. Br J Dermatol 98 (2): 229–231
Ariza J, Gudiol F, Rufi G, Priu R (1977) Tratamiento de la brucelosis aguda con trimetoprim-sulfametoxazol. Med Clin (Barc) 69: 437–441
Arroyo D, Noriega AR (1976) Experience with trimethoprim-sulphamethoxazole in the treatment of chronic brucellosis. In: Williams JD, Creddes AM (eds) Proc 9 th Int Congr Chemother, London, M-629 (Abstr). Plenum, New York
Bach MC, Monaco AP, Finland M (1973a) Pulmonary Nocardiosis: Therapy with minocycline and with erythromycin plus ampicillin. JAMA 224: 1378–1381
Bach MC, Sabath LD, Finland M (1973b) Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother 3: 1–8
Baikie AG, MacDonald CB, Mundy GR (1970) Systemic nocardiosis treated with trimethoprim and sulfamethoxazole. Lancet 2: 261
Barba G, Merlo N (1972) L’associazione trimetoprim-sulfametossazolo nel trattamento della infezione brucellare. G Mal Infett Parassit 24 (2): 79–84
Barbosa W, Vasconcelos WMP (1973) Acao da sulfametoxazol associada ao trimetoprim na terapeutica da blastomicose Sul-Americana. Rev Patol Trop 2 (3): 329–339
Barnett M, Bushby SRM (1970) Trimethoprim and the sulfonamides. Vet Rec 87: 43–51
Barrow GI, Hewitt M (1971) Skin infection with Mycobacterium marinum from a tropical fish tank. Br Med J 2 (5760): 505–506
Bassett DJ (1971) The sensitivity of Pseudomonas pseudomallei to trimethoprim and sulfamethoxazole in vitro. J Clin Pathol 24: 798–800
Bassett DCJ, Stokes JJ, Thomas WRG (1970) Wound infection with Pseudomonas multivorous. A water-borne contaminant of disinfectant solutions. Lancet 1: 1188–1191
Beaumont RJ (1970) Trimethoprim as a possible therapy for Nocardiosis and Melioidosis. Med J Aust 2: 1123–1127
Beeler BA, Wann LS, Bushby SRM, Brooks GF (1975) Sulfamethoxazole-Trimethoprim (SMX-TMP) in the treatment of pulmonary nocardiosis. In: Williams JD, Geddes AM (eds) Proc 9th Int Congr Chemother, London, M-637 (Abstr). Plenum, New York
Bennett JE, Jennings AE (1978) Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother 13: 624–627
Bertaggia A (1975) The parenteral (intravenous and intramuscular) use of trimethoprim-sulfamethoxazole. Clin Ter 75: 611–633
Billi O, Frongillo RF (1971) Clinical trials with a new bactericidal preparation: the trimethoprim sulphamethoxazole association. Riforma Medica 85 (14): 378–384
Black MM, Eykyn SJ (1977) The successful treatment of tropical fish tank granuloma (Mycobacterium marinum) with co-trimoxazole. Br J Dermatol 97 (6): 689–692
Black WA, McNellis DA (1970) Sensitivity of Nocardia to trimethoprim and sulfamethoxazole in vitro. J Clin Pathol 23: 423–426
Blessing J, Lewiston NJ (1976) Pseudomonas in cystic fibrosis sputum: sensitivity to oral antibiotics. Am Rev Respir Dis 113 (4): 37
Brown GL (1973) Clinical aspects of Q fever. Postgrad Med J 49: 539–541
Brown KGE, Molesworth BD, Gjalt-Boerrigter FG, Tozer RA (1974) Disseminated Histoplasmosis duboisii in Malawi: Partial response to sulfonamide/trimethoprim combination. East Afr Med J 51 (5): 584–590
Bushby SRM (1973) Trimethoprim-sulfamethoxazole: in vitro microbiologic aspects. J Infect Dis [Suppl] 128: 442–462
Butler T, Bell WR, Link NN, Tiep ND, Arnold K (1974) Yersinia pestis infection in Vietnam. I. Clinical and hematologic aspects. J Infect Dis [Suppl] 129: S 78 – S 84
Butler T, Levin J, Link NN (1976) Yersinia pestis infection in Vietnam. II. Quantitative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis 133(5):493–499
Calonghi GF, Signorini C, Fassio PG (1973) Ulteriori indagini sulla sensibilità in vitro di ceppi di brucella umana e bovina all’associazione sulfametossazolo-trimetoprim. G Mal Infett Parassit 25 (2): 129–131
Calonghi GF, Goglio A, Marchiaro G, Fassio PG, Auriemma L, Gavazzeni G (1978) On the treatment of acquired toxoplasmosis with co-trimoxazole. G Mal Infett Parassit 30 (2): 204–206
Cantalamessa S, Russo N, Vetrano A (1972) Esperienze cliniche sull’uso del trimethoprimsulfametossazolo nella brucellosi. G Mal Infett Parassit 24 (12): 905–907
Carroll GF, Brown JM, Haley LD (1977) A method for determining in vitro drug susceptibilities of some nocardia and actinomadurae. Results with 17 antimicrobial agents. Am J Clin Pathol 68: 279–283
Caughey JE (1977) Pleuropericardial lesion in Q fever. Br Med J 1 (6074): 1447
Cellesi C, Barberi A, Terragna A (1973) Activity of the trimethoprim-sulfamethoxazole combination in the mouse (Histochemical study). Boll Ist Sieroter Milan 52 (1): 70–76
Chalhoub ES (1976) Brucellosis: its treatment with co-trimoxazole. J Kuwait Med Assoc 10: 51–53
Colonnello F, Calonghi GF, Signorini C (1970) Sensibilità in vitro di ceppi di brucelle isolate dall’uomo e dai bovini all’associazione trimetoprim-sulfametossazolo. G Mal Infett Pa-rassit 22: 481–482
Cook FV, Farrar E (1978) Treatment of Nocardia asteroides infection with trimethoprimsulfamethoxazole. South Med J 71: 512–515
Crowngold T (1977) Susceptibility of Yersinia pestis to trimethoprim and sulfamethoxazole, singly and in combination, as well as to amoxicillin. S Afr J Med Lab Technol 23 (2): 15–18
Cunningham MJ, White PM, Samman PD (1978) Co-trimoxazole resistant Mycobacterium marinum. Br J Dermatol 99 (5): 597
D’Alessandro L, Faenza L, Di Palma D, Russo P (1974) L’associazione TM-SMX nel trattamento della brucellosi. Minerva Med 65 (41): 2350–2356
Daikos GK, Papapolyzos N, Marketos N, Mochlas S, Kastanokis S, Papasteriadis E (1973) Trimethoprim-sulfamethoxazole in brucellosis. J Infect Dis [Suppl] 128: 731–733
Dalovisio JR, Pankey GA (1978) Antibiotic sensitivity profile of Mycobacterium cheloni and Mycobacterium fortuitum. Clin Res 26: 27A
Da Silva YPS, Nunes MP, Suassuna I (1975) Estudo, In Vitro, sobre a susceptibilidade de Yersinia pestis isoladas no Brasil as sulfonamidas, tetraciclinas, aminoglicosideos, penicilinas e esitromicinas. Rev Assoc Med Bras 21 (7): 204–206
Debois J, Degreef H, Vandepitte J, Staepen J (1975) Pseudomonas putrefaciens as a cause of infection in humans. J Clin Pathol 28(12):443–446
DeBuse PJ, Henderson A, White M (1975) Melioidosis in a child in Papua New Guinea: Successful treatment with kanamycin and trimethoprim-sulphametoxazole. Med J Aust 2 (12): 476–478
Degreef H, Debois J, Vandepitte J (1975) Pseudomonas putrefaciens as a cause of infection of venous ulcers. Dermatologica 151: 296–301
Derrick EH (1937) “Q” fever, a new fever entity: clinical features, diagnosis and laboratory investigation. Med J Aust 2:281–283
Domart A, Robineau M, Carbon C (1973) La toxoplasmose acquise: une nouvelle chimiothérapie: l’association sulfamethoxazole-trimethoprime. Nouv Presse Med 2 (5): 321–322
Egere JV, Gugnani HC, Okoro AN, Suseelan AV (1978) African histoplasmosis in eastern Nigeria: report of two culturally proven cases treated with Seprin and Amphotericin B. J Trop Med Hyg 81 (11): 255–229
Ekström B, Fellner H, Forsgren U, Magni L, Ortengren B (1979) Antibacterial activity of co-trimazine in vitro and in vivo. Infection 7 (2): 74–80
Escalona E (1969) Micetoma actinomicosico, su tratamiento con trimetoprim-gantanol. Rev Med Hosp Gen Mex 32: 827–833
Evans RA, Benson RE (1971) Complicated nocardiosis successfully treated with trimethoprim and sulfamethoxazole. Med J Aust 1 (13): 684–685
Everett ED, Kishimoto RA (1973) In vitro sensitivity of 33 strains of Pseudomonas pseudomallei to trimethoprim and sulfamethoxazole. J Infect Dis [Suppl] 128: S539 - S542
Eyles D, Coleman N (1953) Synergistic effect of sulfadiazine and Daraprim against experimental toxoplasmosis in the mouse. Antibiot Chemother 3: 483–490
Feldman HA (1973) Effects of trimethoprim and sulfisoxazole alone and in combination on murine toxoplasmosis. J Infect Dis 128 (S):S 774–776
Felegie T, Yu VL, Rumans LW, Yee RB (1979) Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother 16 (6): 833–837
Fiori GP, Poggio A, Marchesi E (1978) Co-trimoxazole and human brucellosis: a clinical and therapeutic evaluation. G Mal Infett Parassit 30 (2): 173–176
Fischer JJ (1973) Pseudomonas maltophilia endocarditis after replacement of the mitral valve: a case study. J Infect Dis [Suppl] 128:S 771–S 773
Fomufod AK, Antia AV (1971) Successful treatment of subcutaneous phycomycoses with trimethoprim-sulfamethoxazole (Septrin). Trop Geogr Med 23: 208–211
Frazier A, Rosenow EC, Roberts GD (1975) Nocardiosis. A review of 25 cases occurring during 24 months. Mayo Clin Proc 50 (11): 657–663
Freeman R, Hodson ME (1972) Q fever endocarditis treated with trimethoprim and sulfamethoxazole. Br Med J I (5797): 419–420
Frezzotti R, Terragna A, Rossolini A, Bardelli AM, Cellesi C, Figura N (1978) Attinità del co-trimoxazolo nella toxoplasmosi studio sperimentale e clinico. G Mal Infett Parassit 30 (2): 199–204
Fuchs F, Kimball AC, Kean BH (1974) The management of toxoplasmosis in pregnancy. Clin Perinatol 1: 407–422
Fuller PB, Fisk DE, Byrd RB, Griggs GA, Smith MR (1978) Treatment of pulmonary melioidosis with combination of trimethoprim and sulfamethoxazole. Chest 74 (2): 222–224
Furtado T, Marcos AR, Maia FAA (1975) Treatment of South American blastomycosis by trimethoprim-sulfamethoxazole combination. Folha Med 71 (3): 275–279
Gambarella A, Caporale L, Molinaro F (1978) Trimethoprim-sulfamethoxazole in the treatment of lymphonodal toxoplasmosis. Policlin Sezione Med 85 (2): 124–130
Ganesapillai T, Rajagopalan K, Kannan-Kutty M (1978) Trimethoprim-sulfamethoxazole as an additional drug for the deep cutaneous and systemic mycoses. Dermatol SE Asia: 76–81
Geddes AM, Goodall JAD, Boosey CM (1973) Studies with intravenous trimethoprim. In: Daikos GK (ed) Proc 8th Int Congr Chemother, vol 2. Hellenic Society of Chemotherapy, Athens, pp 225–228
Geisler PJ, Check F, Lamothe F, Anderson BR (1979) Failure of trimethoprim/sulfamethoxazole in invasive Nocardia asteroides infection. Arch Intern Med 139 (3): 355–356
Giunchi G, de Rosa F, Fabiani F (1971) Trimethoprim-sulfamethoxazole combination in the treatment of acute human brucellosis. Chemotherapy 16: 332–335
Giunchi G, de Rosa F, Fabiani F (1972) The treatment of acute brucellosis in humans with the trimethoprim-sulphamethoxazole combination. G Mal Infett Parasit 24 (2): 77–79
Gottlieb LS, Chatterjee SN (1979) Disseminated nocardiosis in a compromised host. Dial Transplant 8 (4): 342–343
Grateau P, Pons J, Rigaud A, Pasturel A, Thuing S (1975) Rinoentomophtoromycose: à propos d’une nouvelle observation. Med Armees 3 (4): 291–310
Greenham R (1979) Subcutaneous phycomycosis: not always benign. Lancet 1: 97–98
Grossman PL, Remington JS (1979) The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo. Am J Trop Med Hyg 28 (3): 445–455
Grossman PL, Krahenbuhl JL, Remington JS (1978) In vivo and in vitro effects of trimethoprim and sulfamethoxazole on Toxoplasma infections. In. Siegenthaler W, Lüthy R (eds) Proc 10th Int Congr Chemother, vol 1. Am Soc Microbiol, Washington DC
Hamal PB (1974) Primary pulmonary nocardiosis: case report. Thorax 29 (3): 382–386
Hamilton J, Burch W, Grimmett G, Orme K, Brewer D, Frost R, Fulkerson C (1973) Successful treatment of Pseudomonas cepacia endocarditis with trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother 4 (5): 551–554
Hassan A, Erian MM, Farid Z, Hathout SD, Sorensen K (1971) Trimethoprim-sulfamethoxazole in acute brucellosis. Br Med J 3: 159–160
Havas L (1975) The treatment of some deep mycoses (South American blastomycosis, nocardiosis and actinomycetoma) with a combination of sulfamethoxazole + trimethoprim (bactrim, septrin) — literature review. Mykosen 18 (6): 263–273
Hilson GRF, Banerjee DK, Holmes IB (1971) The activity of various antituberculosis drugs in suppressing experimental Mycobacterium leprae infection in mice. Int J Lepr 39 (2): 349–353
Hokama S (1976) In vitro sensitivity of the sulfonamides against atypical mycobacteria. Tuberculosis 51 (7): 287–291
Holmes B, Lapage SP, Easterling BG (1979) Distribution in clinical material and identification of Pseudomonas maltophilia. J Clin Pathol 32: 66–72
Huys J, Freyens P, Kayihigi J, Van den Berghe G (1973) Treatment of epidemic typus. A comparative study of chloramphenicol, trimethoprim-sulfamethoxazole and doxycycline. Trans R Soc Trop Med Hyg 67 (5): 718–721
Jaffe JJ, McCormack JJ, Meymarian E (1972) Comparative properties of schistosomal and filarial dihydrofolate reductases. Biochem Pharmacol 21: 719–731
Jayareewal FRB, Attopatu M, de Fonseka I, Ratnaike VT (1975) Case report; histoplasmosis of the buccal cavity. Ceylon Med J 20: 45–47
John JF Jr (1976) Trimethoprim-sulfamethoxazole therapy of pulmonary meloidosis. Am Rev Respir Dis 114 (5): 1021–1025
Jonquieres EDL, Bena JL, Negroni R (1975) Systemic histoplasmosis successfully treated with trimethoprim-sulfamethoxazole. Arch Argent Dermatol 25 (1): 95–97
Kamalam A, Thambiah AS (1978) Lymph node invasion by Conidiobolus coronatus and its spore formation in vivo. Sabouraudia 16 (3): 175–184
Katz P, Fanci AS (1977) Nocardia asteroides sinusitis. Presentation as a trimethoprim-sulfamethoxazole responsive fever of unknown origin. JAMA 238(22):2397–2398
Kean BH (1972) Clinical toxoplasmosis — 50 years. Trans R Soc Trop Med Hyg 66: 549–571
Keczkes K (1974) Tropical fish tank granuloma. Br J Dermatol 91: 709
Kelly R (1976) Mycobacterium marinum infection from a tropical fish tank: Treatment with trimethoprim and sulfamethoxazole. Med J Aust 2(18):681–682
Keri J, Telegdy L (1975) Experience gained in the treatment of human brucellosis. Ory Hetil 7: 375–379
Kimbrough RC, Ormsbee RA, Peacock M, Rogers WR, Bennetts RW, Raof J, Krause A, Gardner C (1979) Q fever endocarditis in the United States. Ann Intern Med 91 (3): 400–402
Kirk J, Kaminski GW (1976) Mycobacterium marinum infecton. Aust J Dermatol 17(3):111–116
Kouba K, Nevarilova A, Rajlichova J (1978) Septrin in the treatment of human toxoplasmosis. Cesk Epidemiol Mikrobiol Immunol 27 (3): 175–178
Kremer EP (1972) Pulmonary and cerebral nocardial abscess. Med J Aust 2 (10): 538–540
Ktenidou KS, Papaikonomou K, Papapanagiotou J (1974) Sensitivity of Brucella melitensis to chemotherapeutic agents. Acta Microbiol Hell 19 (5): 314–313
Kuschnaroff TM, Takeda AK, Galvao PAA, Pessoa MC, Lomar AV (1973) Nota prévia a respeito de nova droga usada no tratamento de toxoplasmose. Folha Med 67(4): 617621
Lafrenz M, Ziegler K, Sanger R, Budde E, Naumann G (1973) Neue Aspekte bei der Behandlung der Toxoplasmose. Muench Med Wochenschr 115: 2057–2061
Lal S, Modawal KK, Fowle ASE, Peach B, Popham RD (1970) Acute brucellosis treated with trimethoprim and sulfamethoxazole. Br Med J 3 (5717): 256–257
Laraya-Cuasey LR, Lipstein M, Huang NN (1977) Pseudomonas cepacia in the respiratory flora of patients with cystic fibrosis (CF). Pediatr Res 11(4):502
Laszlo A, Eidus L (1978) Inhibition of fast growing mycobacteria with trimethoprim (TMP). J Antimicrob Chemother 4 (6): 582–583
Leelarasamee A, Vanichakarn S, Aswapokee P, Aswapokee N, Nilvarangkur S, Jaroonvesma N (1977) Disseminated nocardiosis after pulmonary collapse: a case report. Southeast Asian J Trop Med Public Health 8 (4): 558–562
Lopes CF (1976a) Associacâo sulfametoxazol-trimetoprim do tratamento do micetoma actinomicotico por Nocardia brasiliensis. Folha Med 73: 89–92
Lopes CF (1976b) Treatment of South American blastomycosis with the sulfamethoxazoletrimethoprim combination. An Bras Dermatol 51 (3): 207–213
Lopes CF, Armond S (1968) Ensaio terapêutico em casos sulfa-resistentes de blastomicose Sul-Americana. Hospital (Rio de J) 73: 1245–1255
Lopes CF, Cisalpino EO, Armond S, Porto RV, Maia FAA, Peixoto V (1971) Dermatoses tratadas por associacâo sulfametoxazol e trimetoprim. Folha Med 62 (2): 167–172
Lopez TS, Alonso EC, Estevez IF, Gonzalez RA (1976) Brucellosis: consideraciones clinicas y terapéuticas. Revision de 50 casas. Rev Clin Esp 141 (2): 131–137
Lyons C, Owens CR, Ayers WB (1943) Sulfonamide therapy in actinomycotic infections. Surgery 14: 99–103
Machado O, Dantos A, Silva S, Gomes JFR (1967) Observacóes sobre a atividale do sulfametoxazol no tratamento da toxoplasmose. Rev Inst Med Trop Sao Paulo 9: 346–349
Macleod WM (1970)… and histoplasmasis. Lancet II:363
Macleod WM, Murray IG, Davidson J, Gibbs DD (1972) Histoplasmosis: a review, and account of three patients diagnosed in Great Britain. Thorax 27: 6–17
Maderazo EG, Quintiliani R (1974) Treatment of nocardial infection with trimethoprim and sulfamethoxazole. Am J Med 57: 671–675
Maderazo EG, Berlin BB, Morhardt C (1979) Treatment of malakoplakia with trimethoprim-sulfamethoxazole. Urology 13 (1): 70–73
Mahgoub ES (1972) Treatment of actinomycetoma with sulfamethoxazole plus trimethoprim. Am J Trop Med Hyg 21: 332–335
Mahgoub ES (1977) Mycoses of the Sudan. Trans R Soc Trop Med Hyg 71: 184–188
Maibach HI, Gorham W, Aly R (1975) Nocardia brasiliensis mycetoma: treatment with cotrimoxazole. Arch Dermatol 111: 656
Maier W von, Piekarski G (1976) Experimentelle Untersuchungen über die Wirksamkeit der Kombination Sulfamoxol/Trimethoprim (CN 3123) auf die Toxoplasma-Infektion der weißen Maus. Arzneim Forsch (Drug Res) 26 (42): 620–622
Marcovitch H, Norman AP (1970) Treatment of nocardiosis. Lancet 2: 362–363
Martinson FD (1971) Chronic phycomycosis of the upper respiratory tract. Am J Trop Med Hyg 20 (3): 449–455
May J (1979) Disseminated nocardiosis in an immunosuppressed host. Response to trimethoprim-sulfamethoxazole. Rocky Mt Med J 76 (3): 133–134
Minoprio JL (1976) Relazione su un’epidemia di brucellosi nella regione de Huanacache (Mendoza) debellata mediante l’associazione trimethoprim-sulfametossazolo. Clin Ter 11 (3): 217–221
Mössner G (1970) Klinische Ergebnisse mit dem Kombinationspräparat Sulfamethoxazol + Trimethoprim. In: Umezawa H (ed) Proc 6th Int Congr Chemother, vol 1. University Park Press, Baltimore, pp 966–970
Moody MR, Young VM (1975) In vitro susceptibility of Pseudomonas cepaciai and Pseudomonas maltophilia to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother 7 (6): 836–839
Morrison IM (1970) Chronic melioidosis. Proc R Soc Med 63: 289–290
Morrison RE, Young EJ, Harper WK, Maldonado L (1979) Chronic prostatic melioidosis treated with trimethoprim-sulfamethoxazole. JAMA 241: 500–501
Myerowitz RL, Pasculle AW, Dowling JN, Pazin GJ, Puerzer M, Yee RB, Rinaldo CR, Hakala TR (1979) Opportunistic lung infection due to “Pittsburgh pneumonia agent.” N Engl J Med 301 (18): 953–958
Negroni R, Rubinstein P, Gonzalez-Montaner J (1977) Tratamiento de la histoplasmosis cronica con sulfimetoxazol-trimetoprima. Med Cutan Iber Lat Am 1: 71–76
Neu HC, Garvey GJ, Beach MP (1973) Successful treatment of Pseudomonas cepacia endocarditis in a heroin addict with trimethoprim-sulfamethoxazole. J Infect Dis [Suppl] 128: S 768 – S 770
Nguyen BT, Stadtsbaeder S (1975) In vitro activity of cotrimoxazole on the intracellular multiplication of Toxoplasma gondii. Pathol Eur 10: 307–315
Nguyen BT, Stadtsbaeder S, Horvat F (1978) Comparative effect of trimethoprim and pyrimethamine, alone and in combination with a sulfonamide, on Toxoplasma gondii: In vitro and in vivo studies. In: Siegenthaler W, Lüthy R (eds) Proc 10th Int Congr Chemother, vol 1. Am Soc Microbiol, Washington DC, pp 137–140
Nitidandhaprabhas P, Sittapairochana D (1975) Treatment of nocardial mycetoma with trimethoprim and sulfamethoxazole. Arch Dermatol 111: 1345–1348
Nord C-E, Waldstrom T, Wretlind B (1974b) Sensitivity of different Pseudomonas species and Aeromonas hydrophila to trimethoprim and sulfamethoxazole separately and in combination. Med Microbiol Immunol (Berl) 160 (1): 1–7
Nord C-E, Wadstrom T, Wretlind B (1974a) Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother 6 (4): 521–523
Norrby R, Eilard T, Svedhem A, Lycke E (1975) Treatment of toxoplasmosis with trimethoprim-sulfamethoxazole. Scand J Infect Dis 7: 72–75
Ochoa AG (1971) Trimethoprim and sulfamethoxazole in pregnancy. JAMA 217: 1244
Ochoa AG, Tamayo L (1969) Tratamiento del micetoma actinomicético por N. brasiliensis con Ro 6–2580/11. Comunicacion preliminar. Med Rev Mex 49: 473–476
Oomen LJA (1976) Human brucellosis in Kenya. Trop Geogr Med 28: 45–53
Paradisi F, Cristiano P, Cioffi R (1976) Un caso di toxoplasmosi acquisita trattata con cotrimossazolo. G Mal Infett Parassit 23 (12): 719–722
Paschetta G (1972) Sulfametossazolo-trimetoprim e vàccinoterapia nella cura della brucellosi. G Mal Infett Parasit 24 (5): 386–388
Patrick S, Hindmarch JM, Hague RV, Harris DM (1975) Meningitis caused by Pseudomonas maltophilia. J Clin Pathol 28 (9): 741–743
Pavillard ER (1973) Treatment of Nocardial infection with Trimethoprim/Sulfamethoxazole. Med J Aust [Suppl] 1: 65–69
Peabody JW Jr, Seabury JH (1960) Actinomycosis and nocardiosis. Am J Med 28: 99–115
Pedrosa PN, Wanke B, Coura JR (1974) Emprego da associaç’do sulfametoxazol + trimetoprim no tratamento da paracoccidioidose (blastomicose Sul-Americana). Rev Soc Bras Med Trop 8 (3): I59–165
Peniche J, Minor A, Lavalle P (1969) El tratamiento de los micetomas actinomiceticos con gantanol-trimetoprim (Ro 6–2580). Resultadas en 15 pacientes. Dermatologia (Mex) 13: 309–317
Peterson DL, Hudson LD, Sullivan K (1978) Disseminated Nocardia caviae with positive blood cultures. Arch Intern Med 138 (7): 1164–1165
Philippon A, Kazmierczak A, Névot P (1972) Traitement de la brucellosis de la souris par les antibiotiques (tetracycline, ampicilline, triméthoprime-sulfaméthoxazole) en association avec Corynebacterium parvum. Ann Inst Pasteur 123: 349–362
Phillips I, Eykyn S, Curtis MA, Snell JJS (1971) Pseudomonas cepacia (multivorans) septicemia in an intensive-care unit. Lancet 1: 375–377
Pilet C, Monteil JC (1972) In vitro study of the combination of sulfamethoxazole and trimethoprim against different strains of Brucella. Bull Assoc Fr Vet Microbiol Immunol Spec Mal Infect 11: 43–52
Pinkhas J, Oliver I, de Vries A, Spitzer SA, Henig E (1973) Pulmonary nocardiosis complicating malignant lymphoma successfully treated with chemotherapy. Chest 63: 367–370
Poirier R, Colognac-Chapelon R, Kleisbauer JP, Peloux Y, Laval P (1979) Broncho-pneumopathies à Nocardia asteroides. Nouv Presse Med 8 (20): 1693
Porto A (1978) The treatment of rickettsial Boutonneuse fever with cotrimoxazole. 14th Ann Meet Int Soc Interim Med Rome 1978, NO 354. Karger, Basel
Porto A, Barreto A, Mauricio H (1974) Comparacào de dols esquemas terapêuticos da brucelose aguda. J Med (Porto) 88 (1627): 148–149
Rachal JJ, Simberkoff MS, Hyams PJ (1973) Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide and polymyxin B. J Infect Dis [Suppl] 128: S 762–767
Remington JS (1976) Trimethoprim-sulfamethoxazole in murine toxoplasmosis. Antimicrob Agents Chemother 9: 222–223
Rigatos GA, Polyzos AK, Kappos-Rigatou I (1975) Die Trimethoprim-SulfamethoxazolKombination zur Behandlung der Brucellose. Muench Med Wochenschr 117 (22): 961–962
Rivera JV, Perez JB (1957) Pulmonary nocardiosis treated with chloramphenicol. Arch Intern Med 100: 152–156
Robertson L, Farrell ID, Hinchliffe PM (1973) The sensitivitiy of Brucella abortus to chemotherapeutic agents. J Med Microbiol 6 (4): 549–557
Rodriguez JAG, Luengo FM, Galin JLV (1979) Nocardiosis pulmonar: descripción de un caso. Med Clin (Barc) 73: 73–76
Roux J, Van Lam N, Andriambololona L (1974) Sctivité antibactérienne de l’association sulfaméthoxazole-triméthoprime. J Med Montp 9 (4): 162–167
Saksun JM, Kaye J, Schachter RK (1978) Mycetoma caused by Nocardia madurae. Can Med Assoc J 119 (8): 911–914
Sander J, Midtvedt T (1970) The effect of trimethoprim an acute experimental toxoplasmosis in mice. Acta Pathol Microbiol Scand [B] 78: 664–668
Saravolatz LD, Pohlad DJ, Quinn EL (1979) In vitro susceptibility of Legionella pneumophila, serogroups I–IV. J Infect Dis 140 (2): 251
Satterwhite TK, Wallace RJ (1979) Primary cutaneous nocardiosis. JAMA 242 (4): 333–336
Schmidt U, Sen P, Kapila R, Levy F, Lange M, Middleton J, Louria DB (1980) Clinical experience with intravenous trimethoprim-sulfamethoxazole (SXT) for serious infections. In: Nelson JD, Grassi C (eds) 19th Intersci Conf Antimicrob Agents Chemother, Boston, Oct 1–5, 1979. Am Soc Microbiol, Washington DC
Seah SKK (1975) Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations. Am J Trop Med Hyg 78 (7): 150–153
Seligman SJ, Madhavan T, Alcid D (1973) Trimethoprim-sulfamethoxazole in the treatment of bacterial endocarditis. J Infect Dis [Suppl] 128: S754 - S761
Seriki O, Aderele WI, Johnson A, Smith JA (1975) Disseminated histoplasmosis due to Histoplasma capsulatum in two Nigerian children. J Trop Med Hyg 78 (12): 248–255
Shashindran CH, Gandhi IS, Krishnasamy S, Ghosh MN (1978) Oral therapy of pediculosis capitis with cotrimoxazole. Br J Dermatol 98 (6): 699–700
Shashindran CH, Gandhi IS, Lal S (1979) A trial of cotrimoxazole in scabies. Br J Dermatol 100 (4): 483
Sher NA, Hill CW, Eifrig DE (1977) Bilateral intraocular Nocardia asteroides infection. Arch Ophthalmol 95 (8): 1415–1418
Sierra F, Restrepo A, Moncada LH (1974) Nocardiosis pulmonar. Antioquia Med 24 (1): 65–69
Singh D, Kochhar RC, Seth HN (1976) Clinical records: rhinoentomophthoromycosis. J Laryngol Otol 90 (9): 871–875
Speller DCE (1972) Pseudomonas cepacia endocarditis treated with co-trimoxazole and kanamycin. Br Heart J 35:47–48
Stadtsbaeder S, Calvin-Preval MC (1973) L’association trimethoprim + sulfamethoxazole au cours de la toxoplasmose experimentale chez la souris. Acta Clin Belg 28 (1): 34–39
Steigman AJ (1977) Rocky Mountain spotted fever and the avoidance of sulfonamides. J Pediatr 91 (1): 163–164
Sueri L (1972) Prime osservazioni sul trattamento della brucellosi con l’associazione trimethoprim-sulfametossazolo per via orale ed endovenosa. G Mal Infett Parassit 24 (1): 3–7
Sueri LA (1973) Further observations on the treatment of brucellosis with the combination trimethoprim-sulphamethoxazole by oral and intravenous routes. G Mal Infett Parassit 25 (1): 65–67
Sueri L, Ielasi G (1974) The treatment of various infectious diseases by intravenous administration of the trimethoprim-sulfamethoxazole combination (slow infusion). G Mal In-fett Parassit 26 (6): 672–678
Sueri L, Vaglia A, Ciammaruchi R (1978) Terapia della brucellosi con Co-trimoxazolo. G Mal Infett Parassit 30 (2): 168–171
Swenson J, Thornsberry C, Silcox V (1980) Susceptibility of rapidly growing mycobacteria to 33 antimicrobial agents. In: Nelson JD, Grassi C (eds) Proc 11th ICC and 19th ICAAC, Boston, Oct 1–5, 1979. Am Soc Microbiol, Washington DC
Syrkis I, Fried M, Elian I, Pietrushka D, Lengy T (1975) A case of severe human coccidiosis in Israel. Isr J Med Sci 11 (4): 373–377
Szaflarski J, Sokola A, Herman ZS (1974) Tentative treatment of experimental toxoplasmosis in mice. IX. Effect of trimethoprim, sulfomethoxazole and their combination Seprin. Acta Parasitol Pol 22: 261–263
Tanphaichitra D (1979) Acute septicaemic melioidosis with pulmonary hilar prominence: a case report with a unique chest radiographic pattern. Thorax 34 (4): 565–566
Tanphaichitra D, Vanwari S, Siristonpun Y, Promjunyakul K (1979) Melioidosis. Therapy with multiple antimicrobial agents and cellular immunity. Chest 75 (5): 646–647
Taplin D, Bassett DC, Mertz PM (1971) Foot lesions associated with Pseudomonas cepacia. Lancet 2 (7724): 568–571
Telegdy L, Kéri J (1976) Treatment of human brucellosis with doxycycline and trimethoprim-sulfonamide. In: Williams JD, Geddes AM (eds) Proc 9 th Int Congr Chemother, London, vol 6. Plenum, New York, pp 379–382
Terragna A, Rossolini A, Cellesi C, Figura N, Barberi A (1973) Activity of the combination trimethoprim-sulfamethoxazole on experimental toxoplasmosis. Arzneim Forsch 23 (9): 1328–1331
Terragna A, Cellesi C, Rossolini A, Figura N (1974a) Attività dell’associapione trimethoprim-sulfamethossazolo (TM-SMZ) nella toxoplasmosi sperimentale del topo. G Mal Infett Parassit 26 (7): 861–867
Terragna A, Rossolini A, Cellesi C, Figura N (1974b) L’associazione trimethoprim-sulfametossazolo ( TM-SMZ) nella toxoplasmosi sperimentale del topo. Gaz Med Ital 133: 330–336
Thianprasit M (1978) Successful treatment of basidiobolomycosis with trimethoprim and sulfamethoxazole. Dermatol SE Asia (SEAMEO): 82–83
Thiermann E, Apt W, Atias A, Lorca M, Olguin J (1978) A comparative study of some cornbined treatment regimens in acute toxoplasmosis in mice. Am J Trop Med Hyg 27 (4): 747–750
Thornsberry C, Baker CN, Kirven LA (1978) In vitro activity of antimicrobial agents on Legionnaires disease bacterium. Antimicrob Agents Chemother 13 (1): 78–80
Tomioka S, Kobayashi Y, Uchida H (1978) Susceptibilities of glucose-nonfermentative gram-negative rods to antimicrobial agents. In: Siegenthaler W, Lüthy R (eds) Proc 10th Int Congr Chemother, Zurich, Sept 18–23, vol 1. Am Soc Microbiol, Washington DC, pp 440–442
Turner T, Burry JN, Kirk J, Reid JG (1975) Mycobacterium marinum infection. Arch Dermatol 111(4):525
Van-Ai N, Duc-Hanh N, Van-Dien P, Van-Lè N (1972a) Effets in vitro et in vivo du triméthoprime-sulfaméthoxazole sur Yersinia pestis. Bull Soc Pathol Exot Filiales 65 (4): 759–764
Van-Ai N, Duc-Hanh N, Van-Dien P, Van-Lè N (1972b) Peste bubonique et septicémique traitée avec succès par du triméthoprime-sulfaméthoxazole. Bull Soc Pathol Exot Filiales 65 (6): 770–780
Van-Ai N, Duc-Hanh N, Van-Dien P, Van-Lè N (1973) Co-trimoxazole in bubonic plague. Br Med J 4 (5884): 108–109
Van Beers D, Yourassowsky E (1974) Traitement d’une nocardiose pulmonaire par le cotrimoxazole. Etude clinique et microbiologique. Med Mal Infect 4 (3): 139–144
Wallace JR, Bigby T, Septimus EJ (1980) The activity of sulfonamides against Mycobacterium fortuitum and Mycobacterium cheloni. In: Nelson JD, Grassi C (eds) Proc 11th ICC and 19th ICAAC, Boston, Oct 1–5, 1979. Am Soc Microbiol, Washington DC
Wallace R, Septimus EJ, Musher DM, Martin RR (1977) Disc diffusion susceptibility testing of Nocardia species. J Infect Dis 135: 568–575
Werner H, Egger I (1975) Vergleichende chemotherapeutische Untersuchungen über die Wirksamkeit von Bactrim und anderen Kombinationspräparaten auf die Proliferative-und Zystenbildungsphase von Toxaplasma gondii in NMRI-Mäusen. Zentralbl Bakteriol [B] 231: 349–364
Westerman EL, Christensen RP (1979) Chronic Isospora belli infection treated with cotrimoxazole. 91 (3): 413–414
Willey RF, Matthews MB, Peutherer JF, Marmion BP (1979) Chronic cryptic Q-fever infection of the heart. Lancet II (8137): 270–279
Williams H (1977) Toxoplasmosis in the perinatal period. Postgrad Med J 53 (624): 614–617
Wishart MM, Riley TV (1976) Infection with Pseudomonas maltophilia hospital outbreak due to contaminated disinfectant. Med J Aust 2 (19): 710–712
Woolfson H, Saunders KE, Meade G (1976) Fish tank granuloma. Br J Clin Pract 30(5): 122–127
Yu VL, Rumans LW, Wing EJ, McLeod R, Sattler FN, Harvey RM, Deresinski SC (1978) Pseudomonas maltophilia causing heroin-associated infective endocarditis. Arch Intern Med 138(11):1667–1671
Yu VL, Felegie TR, Yee RB, Pasculle AW (1980) In vitro synergism with the use of three antibiotics simultaneously against P. maltophilia. In: Nelson JD, Grassi C (eds) 19th Intersci Conf Antimicrob Agents Chemother, Boston, Oct 1–5, 1979, No 587. Am Soc Microbiol, Washington DC
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Desjardins, R.E. (1983). Treatment of Miscellaneous and Unusual Infections with Trimethoprim and Trimethoprim/Sulfonamide Combinations. In: Hitchings, G.H. (eds) Inhibition of Folate Metabolism in Chemotherapy. Handbook of Experimental Pharmacology, vol 64. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81890-5_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-81890-5_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81892-9
Online ISBN: 978-3-642-81890-5
eBook Packages: Springer Book Archive